Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04383938
Title Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Aprea Therapeutics
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Center Boston Massachusetts 02115 United States Details
Mayo Clinic Rochester Minnesota 55902 United States Details
Washington University Saint Louis Missouri 63130 United States Details
Vanderbilt University Nashville Tennessee 37235 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field